News

  • The world’s largest generic drug company, Announce new name——Viatris
    Post time: Dec-31-2019

    November 12,Mylan and Pfizer announce the name of the new company formed by the planned merger of Mylan and Pfizer subsidiary Upjohn(Pronounced as”viǝ- trīs.) Viatris from Latin, It reflects the goals of the new company, I.e. from “VIA” To three “TRIS” Core goal path...Read more »

  • Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto
    Post time: Dec-06-2019

    The settlement resolves about 25,000 lawsuits, which claimed the companies failed to warn about deadly bleeding episodes caused by the drug.  Johnson & Johnson and Bayer said on Monday that they had agreed to pay $775 million to settle about 25,000 lawsuits involving the blood thinner Xarelto...Read more »

  • Preparation product import business goes further
    Post time: Nov-25-2019

      As one of the leading enterprises in the internationalization of China’s pharmaceutical industry, Unibest pharmaceutical expands its territory and actively carries out the import business of overseas preparations. Pharmaceutical import business has always been the key strategic direc...Read more »

  • The 16th birthday of Unibest
    Post time: Oct-15-2019

      In the golden autumn of 2019, members of Unibest family  gathered together and celebrated the 16th birthday of Unibest . It has been tough years, and we passed on and spanned in those days. and we have been working hand in hand for 16 years. Unibest has grown from a start-up company of two...Read more »

  • FDA approves Vosevi for Hepatitis C
    Post time: Nov-24-2017

    The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. Vosevi is a fixed-dose, combination tablet containing two previously approved drugs – sofosbuvir and velpatasvir...Read more »

  • Post time: Nov-24-2017

    API China, taking place from 16-18 May 2017 in Shanghai, China Read more »

  • Post time: Nov-24-2017

    API China, taking place from 16-18 November 2016 in Wuhan,China Read more »

  • Post time: Nov-24-2017

    CPhI China, taking place from 20-22 June 2017 at SNIEC, Shanghai, China Read more »

  • Post time: Nov-24-2017

    CPhI India 2016 Read more »

  • Post time: Nov-24-2017

    Eleven medicines leap towards EU approval 2016-09-21 15:27:20 Eleven new medicines have taken a giant leap closer to European Union approval after having won the backing of the Committee for Medicinal Products for Human Use. The Committee has put forward three new drugs for the treatment of canc...Read more »

  • Post time: Nov-24-2017

    75 percent higher proportion of relapsing multiple sclerosis (RMS) patients achieved No Evidence of Disease Activity (NEDA) with OCREVUS compared with interferon beta-1a (Rebif ®) 47 percent higher proportion of primary progressive multiple sclerosis (PPMS) patients achieved No Evidence of Progre...Read more »

  • Post time: Nov-24-2017

    Berlin, September 19, 2016 – The U.S. Food and Drug Administration (FDA) has approved Bayer AG’s new low dose levonorgestrel-releasing intrauterine system (LNG-IUS) which will be marketed in the US under the brand name Kyleena™. Kyleena releases the lowest daily dose of the hormone levonorgestrel...Read more »

WhatsApp Online Chat !